Skip to main content
Open Access Publications from the University of California

Risk of serious bloodstream infections is low in pediatric hematopoietic stem cell transplant (HSCT) recipients with fevers due to antithymocyte globulins and alemtuzumab.

  • Author(s): Horn, B
  • O'Kane, S
  • Wattier, RL
  • Wahlstrom, JT
  • Melton, A
  • Cowan, MJ
  • Dvorak, CC
  • et al.
Main Content
Current View